Emerging Nucleic Acid Testing (NAT) Assays, Country Market Shares, Strategic Profiles of Leading Reagent and Instrument Suppliers, 2019

July 2019 | 549 pages | ID: 296E98D11A4EN
Venture Planning Group

Abstracts

This 549-page report presents an overview of the clinical significance and market needs for major current and emerging NAT assays, as well as extensive listings of companies developing and marketing innovative technologies and products.

This report also presents strategic assessments of current and emerging suppliers of nucleic acid testing products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 549 pages and 22 tables

Contents

MICROBIOLOGY/INFECTIOUS DISEASES

a. Overview
b. Major Infectious Diseases
  AIDS
  Structure and Composition
  Classification
  AIDS Origins
  Animal Lentivirus Systems
  Virus Receptors
  HIV Infections in Humans
  Pathogenesis and Pathology
  CD4T Lymphocytes and Memory Cells
  Monocytes and Macrophages
  Lymphoid Organs
  Neural Cells
  Viral Coinfections
  Clinical Findings
  Plasma Viral Load
  Pediatric AIDS
  Neurologic Disease
  Opportunistic Infections
  Cancer
  Immunity
  Virus Isolation
  Serology
  Viral Nucleic Acid/Antigen Detection
  Epidemiology
  Worldwide Spread of AIDS
  United States
  Routes of Transmission
  DNA Probes
  Overview
  Quantitative PCR
  In Situ PCR
  Needed Improvements
  Viral Load/Drug Resistance Testing
  Genotype and Phenotype Testing
  Blood Banking Considerations
    Adenovirus
  Background
  Diagnostic Tests
  Vaccines and Drugs
  Adeno-Associated Viruses (AAV)
    Anthrax/Bacillus Anthracis
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Babesiosis
  Background
    BEA and Other Bartonella Diseases
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Chagas Disease
  Background
    Campylobacter
  Background
  Diagnostic Tests
  Culture Identification
  Vaccines and Drugs
    Chlamydia
  Background
  Chlamydia psittaci
  Chlmaydia pneumoniae
  Chlamydia trachomatis
  Diagnostic Tests
  Vaccines and Drugs
    Creutzfeldt-Jakob’s Disease
  Background
  Blood Transmission
  Diagnostic Tests
  Major Commercial and Academic Players
Bayer
  Disease Sciences/Bio Tec Global
  Imperial College School of Medicine
Ortho-Clinical Diagnostics
  Pall
  ProMetic Life Sciences
Proteome Sciences/Idexx
  Q-One Biotech
  Serono
  U.S. Agricultural Research Service
  Drugs
  Vaccines
    Cytomegalovirus
  Background
  Chorioretinitis
  Gastrointestinal
  Central Nervous System Disease
  Diagnostic Tests
  Vaccines and Drugs
    Ebola Virus
  Background
  Epidemiology
  Clinical Syndromes
  Diagnostic Tests
  Vaccines and Drugs
    EchoVirus
  Background
  Acute Aseptic Meningitisis
  Encephalitis
  Exanthems
  Respiratory Disease
  Myopericarditis
  Neonatal Infections
  Diagnostic Tests
  Vaccines and Drugs
    Encephalitis
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Enteroviruses
  Background
  Diagnostic Tests
  Viral Isolation and Identification
  Antibody Tests
  Vaccines and Drugs
    Epstein-Barr Virus
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Gonorrhea
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Hepatitis
  Hepatitis A
  Hepatitis B
  Structure and Composition
  Replication
  Hepatitis C
  Hepatitis D (Delta)
  Hepatitis E
  Hepatitis G
  Hepatitis Infections Pathology
  Clinical Findings
  Laboratory Tests
  Hepatitis A
  Hepatitis B
  Hepatitis C
  Hepatitis D
  Hepatitis E
  Virus-Host Immune Reactions
  Epidemiology
  Hepatitis A
  Hepatitis B
  Hepatitis C
  Hepatitis D (Delta)
  Vaccines and Drugs
    Herpes Simplex Virus
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Legionella
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Lyme Disease
  Background
  Clinical Description
  Clinical Case Definition
  Laboratory Criteria for Diagnosis
  Case Classification
  Diagnostic Tests
  Vaccines and Drugs
    Malaria
    Mycoplasma
  Background
  Ureaplasma Urealyticum & Mycoplasma Hominis
  Diagnostic Tests
  Vaccines and Drugs
    Papillomaviruses/HPV
  Background
  HPV in Cancer
  Cervical Neoplasm
  Diagnostic Tests
  Vaccines and Drugs
  Prevention
    Parvovirus B19
  Background
  Microbiology
  Epidemiology
  Clinical Syndromes
  Erythema Infectiosum (Slapped Cheek)
  Adult Polyarthropathy
  Transient Aplastic Crisis
  Transient Pancytopenia
  Red Cell Aplasia in Immunocompromised
  Perinatal Infections
  Diagnostic Test
  Vaccines and Drugs
    Pneumonia
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Polyomaviruses
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Salmonellosis
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Shigellosis
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Streptococci
  Background
  Diagnostic Tests
  Vaccines and Drugs
  Group A Streptococci
  Group B Streptococci
    Toxoplasmosis
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Tuberculosis
  Background
  Diagnostic Tests
  Microscopic Characteristics
  Cultural Characteristics
  Skin Tests
  MDRTB
  Vaccines and Drugs
    West Nile Virus
  Background
  Clinical Syndromes
  Diagnostic Tests
  Vaccines and Drugs
    Yersinia
  Background
  Diagnostic Tests
  Vaccines and Drugs
    Antibiotic Susceptibility

CANCER TESTING

a. Overview
b. Major Cancer Types
    Prostate
    Lung
    Colon and Rectum
    Breast
    Skin
    Uterine
    Leukemia
    Oral
c. Oncogenes
  Abl/abl-bcr
  AIB1
  BCL-2
  BRCA1
  CD44
  C-fos
  C-myb
  C-myc
  CYP17
  Erb-B
  HPC1
  N-myc
  P40
  P51
  P53
  PIK3CA
  PTI-1
  Ras
  Reg
  Sis
  Src

GENETIC DISEASES

a. Overview
b. Nucleic Acid Amplification
c. Chromosome Imaging
d. Genomics Technologies
e. Proteomics Technologies
f. Current Pharmacogenomic Tests
g. Future Pharmacogenomic Testing
h. Major Diseases
    Achondroplasia
    Autosomal Dominant Polycystic Kidney Disease
    Cancer
    Cosmetogenomics
    Cystic Fibrosis
    Down's Syndrome
    Duchenne and Becker Muscular Dystrophy
    Factor V (Leiden)
    Factor IX Deficiency
    Fragile X Syndrome
    Heart Disease
    Hemochomatosis
    Hemophilia
    Huntington's Disease
    Maternal-Fetal Incompatibility
    Multiple Endocrine Neoplasia
    Phenylketonuria (PKU)
    Polycystic Kidney Disease (PKD)
    Prenatal Screening
    Retinitis Pigmentosa
    Retinoblastoma
    Sickle Cell Anemia
    Spinal Muscular Atrophy
    Vitamin B12 Metabolism
i. Social Issues and Concerns

FORENSIC TESTING

a. Overview
b. Multilocus and Single Locus Probes
    Multilocus Probes
    Single Locus Probes
    PCR and RFLP
c. The FBI
d. DNA Profile Data Banks
    U.S.A.
    U.K.
e. Judicial Implementation
f. Major Crime Categories
g. Factors Contributing to the DNA Probe Market Expansion
    Technology Availability
    Use of Hair as Evidence
h. Wildlife Forensics

PATERNITY TESTING/HLA TYPING

OTHER APPLICATIONS

a. Disease Susceptibility Testing
b. Cardiovascular Diseases
c. Diabetes
d. Alzheimer's Disease
e. Periodontal Disease
f. Plasma Purification
g. Organ Transplantation
h. Water Contamination
i. Other

COMPETITIVE PROFILES

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/LabCorp
Decode Genetics
Diadexus
Elitech Group
Eiken
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher

List Of Tables

LIST OF TABLES

Major Companies Developing or Marketing AIDS Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Adenovirus
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Campylobacter
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Chlamydia
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing CMV Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing EBV Molecular
Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Gonorrhea
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Hepatitis
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Herpes
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Legionella
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Lyme
Disease Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Mycoplasma
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Papilloma
Virus Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Pneumonia
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Salmonella
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Shigella
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Streptococci
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Toxoplasmosis
Molecular Diagnostic And Other Direct Identification Tests
Major Companies Developing or Marketing Tuberculosis
Molecular Diagnostic And Other Direct Identification Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer
Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular
Diagnostic Test For Genetic Diseases